Business Context and Reporting Period
This Form 8-K Current Report was filed by Healthcare Trust, Inc. (the "Company") on December 6, 2019, covering events occurring on December 5 and December 6, 2019. The filing details the entry into a material definitive agreement for an underwritten public offering of preferred stock and related amendments to the Company's operating partnership agreement and articles of incorporation.
Key Financial Metrics and Transaction Details
- Offering Size: 1,400,000 shares of 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, with a 30-day overallotment option for up to 210,000 additional shares.
- Price per Share: $25.00.
- Liquidation Preference: $25.00 per share.
- Dividend Rate: 7.375% per annum ($1.84375 per share), cumulative.
- Expected Net Proceeds: Approximately $33.9 million (after underwriting discount, excluding other estimated offering expenses).
- Use of Proceeds: General corporate purposes, including funding property acquisitions.
- Expected Closing Date: On or about December 11, 2019.
Material Changes and Structural Modifications
The Company entered into an Underwriting Agreement with B. Riley FBR, Inc. as representative of the underwriters. Concurrently, the Company executed a Third Amendment to its Operating Partnership Agreement to designate Series A Preferred Units with economic interests substantially similar to the Series A Preferred Stock. Additionally, Articles Supplementary were filed to classify 1,610,000 authorized shares as Series A Preferred Stock.
Terms, Risks, and Management Commentary
- Redemption Rights: The stock is redeemable at the Company's option on or after December 11, 2024, at $25.00 per share plus accrued dividends. Early redemption is permitted upon a Delisting Event or Change of Control.
- Delisting Penalty: Upon a Delisting Event, the dividend rate increases by 2.00% per annum to 9.375% ($2.34375 per share) until the event is cured.
- Conversion Rights: Holders may convert shares to Common Stock upon a Change of Control during a continuing Delisting Event if the Company does not exercise its redemption right.
- Voting Rights: Limited to electing two additional directors if six or more quarterly dividends are in arrears, and voting on amendments materially affecting their rights.
- Seniority: Ranks senior to Common Stock regarding dividends and liquidation rights.
- Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ materially from expectations due to risk factors outlined in the Company's 2018 Form 10-K.
Investor Verification Checklist
- Verify the final closing date and actual net proceeds received after all offering expenses.
- Confirm the execution of the Third Amendment to the Operating Partnership Agreement.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific indemnification and covenant details.
- Monitor the Company's liquidity position to ensure ability to pay cumulative dividends, particularly given the 7.375% yield.
- Check for any subsequent filings regarding the exercise of the 30-day overallotment option.